Galmed Pharmaceuticals (Nasdaq: GLMD) enters into a Sponsored Project Agreement with Virginia Commonwealth University (VCU) to evaluate Aramchol's effect on overcoming drug resistance in ...

The safety and efficacy of Eylea HD for RVO and monthly dosing in approved indications have not been evaluated by any regulatory authority. B of A Securities maintains Regeneron Pharmaceuticals ...

Design Therapeutics (DSGN) announced the appointment of Chris Storgard, M.D., as Chief Medical Officer. Most recently, Dr. Storgard served as ...

Becky Clasper, Senior Director - Global Quality and Compliance Alora Pharmaceuticals, LLC is the parent company of six specialty pharmaceutical and pharmaceutical manufacturing companies.

TEL AVIV, Israel, April 15, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company dedicated to developing novel ...

Although President Donald Trump paused most of his biggest tariff hikes last week for 90 days, apart from those for imports from China, he has said he still plans tariffs on pharmaceutical drugs ...

Allen Baharaff, CEO of Galmed Pharmaceuticals commented: "The newly discovered markers showed significant expression in untreated patients at baseline and were reversed following treatment with ...

GlaxoSmithKline (GSK) is set to apply artificial intelligence (AI) technology to improve its drug discovery efforts through a collaboration with Cloud Pharmaceuticals. Its deal with the US-based ...

April 10, 2025 /PRNewswire/ -- Rivus Pharmaceuticals ... Dr. Grainger will oversee the strategy, design and implementation of the clinical development for Rivus' pipeline of CMA drug candidates ...

During the National Republican Congressional Committee dinner in Washington, D.C., President Trump said that his administration would "very shortly" announce tariffs on pharmaceuticals. April 9, 2025 ...

A splash-shaped installation and a glass light imprinted with a tree branch feature in this video edited by Dezeen for Czech glass brand Lasvit as part of Milan design week. Titled Splash ...

Needham analyst Serge Belanger maintained a Buy rating on Pacira Pharmaceuticals (PCRX – Research Report) today and set a price target of $32.00. The company’s shares closed yesterday at $22.91.